Table 4 Ambulatory management of clinically stable preeclampsia at secondary level of care Please also refer to Figures 3, 4, and 5.
Mother | Foetus | ||
|---|---|---|---|
Monitoring: The patient must be seen every third day until admission for delivery. | |||
Clinical | Exams (weekly) | Clinical | Exams |
Blood pressure Weight Look for CNS, renal, cardiovascular or gastrointestinal symptoms at every visit | Blood count (including platelet count) Urinalysis (proteinuria) every third day or Dipstick Liver Function Tests (Bilirrubin, AST, ALT) | Foetal movements Foetal cardiac rate | Cardiotocography: No-stress testing (every 5 to 7 days) Ultrasonography (measure foetal growth, maturity and placental location and amniotic fluid index) |
Treatment | Treatment | ||
Bed rest at home | Anti-hypertensives (controversial) Methyldopa Nifedipine Hydralazine | Induction of pulmonary maturity using dexamethasone or betamethasone in patients with gestational age less than 34 weeks. | Â |